Sana Karam, MD, PhD
@KaramLab
Followers
2K
Following
8K
Media
36
Statuses
2K
Tumor Immunology, TME, Systemic Immunity, Radiation Oncology, Wash U
Saint Louis, MO
Joined November 2020
On the eve of #InternationalDayofMedicalPhysics & #WeWhoCurie we want to highlight one of our #medphys residents! Meet Sarah! We are thrilled to have Sarah here training with us. #IDMP #TrainHereThriveAnywhere #WomenWhoCurie
0
1
5
Shocking! Only 1.4% of global cancer spend is used for surgical research and only 2.8% on radiotherapy research. Please help us learn how to cure more patients by funding curative therapies research! #radonc
The abysmal state of global research funding on key domains such as surgery, radiotherapy and health services. Combined less than 4%. How have research funding organisations managed to get their strategic priorities so wrong? @cspramesh
6
59
134
THIS is an amazing event, ground roots effort by Dr. Lannis Hall @BarnesJewish St Peter’s and the First Ladies of St Louis - free screenings, health info and doctors corner to get answers to your health questions!!!
1
1
1
Now online! Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance
cell.com
Cancer cells exploit distant tissues and organs to escape immune surveillance by activating nociceptive neurons, which remodel tumor-draining lymph nodes into an immune-suppressed state. Blocking...
0
33
121
This is devastating! So many Lebanese are getting cancer from pollution, smoking, and lack of basic health care. https://t.co/DgmckbvncK Come on, fellow Lebanese, let's sprint to action!
apple.news
According to a new report, cancer rates are skyrocketing in this tiny country. What's causing this to happen? And what steps can be taken to turn the tide?
0
0
9
0
1
3
Digital oncology is here to stay. Randomized trial of smartphone assisted follow up shows it prevents deterioration of quality of life in head and neck cancer survivors. Stefano Cavalieri at #ESMO25
1
21
39
Long awaited BURAN in #ESMO2025 : A phase III study of buparlisib plus paclitaxel in patients with CPI pretreated recurrent/metastatic head and neck cancer, no OS benefit overall and in subgroups . Likely effect of post IO era . no biomarker selection for PI3K #MedIQESMO25 #HNSCC
0
2
9
SKYSCRAPER-09 out in #ESMO25 : ORR across both tiragolumab + atezo and atezo + pbo arms was similar to pembrolizumab in PD-L1+ SCCHN .no clear PFS benefit with the addition of tira to atezo vs atezo + pbo in pts with PD-L1+ SCCHN #MedIQESMO25 #HNSCC
0
1
5
#ESMO25 Large Ph3 RCT of 294 patients with LA #NasopharyngealCarcinoma comparing Adj Cap x 6 mo vs observation alone post-CCRT As I have said before Cap is great for NPC esp with low disease burden Great work by my previous mentee Dr Miao_JJ from SYSUCC!
4
9
33
CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome https://t.co/RAXP8PPN08
3
73
314
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors https://t.co/4EjvE8JRAE
3
98
391
#ESMO25 Kicking off ESMO with a bang #HeadNeckCancer Fascinating results of ComPARE trial by @h_mehanna Neoadj and Adj Durva added to CRT vs CRT alone No benefit overall However in subset of high risk OPC, benefit was obvious in local and distant control. Win for the
2
12
38
Very excited to serve as the next Chair/Dept Head @WashUMedENT!! I am truly humbled to lead this storied department and push it higher through collaboration, persistence, and innovation with our incredible faculty/staff as we advance care of #ENT patients.
medicine.washu.edu
Sidharth Puram, MD, PhD, has been named the head of the Department of Otolaryngology — Head & Neck Surgery at WashU Medicine.
13
5
113
HUGE day of FREE health and cancer screenings + seminars organized by the First Ladies of St. Louis! Sat Nov 1, Ferguson MO - register here: https://t.co/mgo1VhSgwe
@AmericanCancer @SitemanCenter @lannis_hall
1
4
8
Our @SitemanCenter @BarnesJewish St Peters team, led by @lannis_hall got to share knowledge with South Korea! Dr. Song came here to learn more about our advanced technique with #prostatecancer seeds #brachytherapy. Global knowledge sharing helps patients! https://t.co/Ds5Ktmllio
0
5
7
🔥When it comes to prognosis, GARD beats clinical variables. 📈 3-yr OS AUC: Clinical factors = 71 GARD alone = 78 Combined = 84 #ASTRO25 (4/7)
1
1
3
🚨 New in @JClinInvest 🚨 HPV+ oropharynx patients do not all benefit equally from the same radiation dose. Our study shows that genomics (via GARD) can guide personalized RT de-escalation—safely sparing toxicity without losing cure. Paper 👉 https://t.co/TEOh9q6qYQ
#ASTRO25
3
19
37
Cell-cell fusion in cancer: The next cancer hallmark? Sharp review article about a surprising finding in our lab. Primary research article to follow... https://t.co/WNMZdT13yf
0
2
6